Rituximab is associated with improved survival for aggressive B cell CNS lymphoma (Q37021529)
scientific article published on March 15, 2013
Language:
(P31) (Q13442814)
(P50) (Q61218949)
(Q80100426)
(Q55445006)
(Q90183397)
(P304) 1068-1073
(P407) (Q1860)
(P433) 8
(P478) 15
(P577) Friday, March 15, 2013
(P921) (Q412323)
(Q5090613)
(P953) https://academic.oup.com/neuro-oncology/article-pdf/15/8/1068/4035222/not032.pdf
https://europepmc.org/articles/PMC3714147
https://europepmc.org/articles/PMC3714147?pdf=render
https://doi.org/10.1093/neuonc/not032
http://academic.oup.com/neuro-oncology/article-pdf/15/8/1068/4035222/not032.pdf
(P1433) (Q15724471)
(P1476) "Rituximab is associated with improved survival for aggressive B cell CNS lymphoma" (language: en)
(P2093) Ashwini Arumugaswamy
Teresa Leung
Melody Abikhair
Ashish Bajel
Lawrence Cher
Andrew Grigg
David Ritchie
(P2860) (Q38031010)
(Q33377067)
(Q36610071)
(Q33264150)
(Q33370808)
(Q34529884)
(Q42849724)
(Q42435631)
(Q47790904)
(Q43253826)
(Q43274038)
(Q48858718)
(Q48329587)
(Q48429596)
(Q48463656)
(Q46690532)
(Q49015161)
(Q44401515)
(Q43506564)
(Q73793902)
(Q80541964)
(Q72118002)
(Q71123768)
(Q80426292)
(Q82954051)
(Q83389320)
other details
description scientific article published on March 15, 2013

External Links